Home Podcasts The Business Of Neurotech
The Business Of Neurotech

The Business Of Neurotech

Adam Fraser 7 Episodes Aug 24, 2026

The Business of Neurotech is a podcast that explores the commercial side of neuroscience, covering topics like neuromodulation, brain-computer interfaces, and medical devices. Hosted by Adam Fraser, it features interviews with founders, CEOs, venture capitalists, and strategic leaders. The show discusses market maturity, regulatory challenges, and go-to-market strategies for neurotechnology. It is aimed at investors, researchers, and entrepreneurs interested in the business of brain tech.

Episodes

Derrick Buchanan talks Stanford, Transcranial Magnetic Stimulation and Neurotech
Derrick Buchanan talks Stanford, Transcranial Magnetic Stimulation and Neurotech Aug 24, 2026 2682 Brain stimulation is moving from specialist clinics towards faster, more personalised and scalable care. In this episode, Adam Fraser speaks with Dr Derrick Buchanan, a clinical neuroscientist in Stanford’s Brain Stimulation Lab, entrepreneur, author and speaker whose work spans precision brain imaging, neuromodulation and mental health. Derrick discusses his path from Canada to Stanford and explo
Matias Serebrinsky talks frontier brain and mental health VC investing
Matias Serebrinsky talks frontier brain and mental health VC investing Aug 10, 2026 2363 What makes an emerging technology bold enough and a founder exceptional enough to justify taking an early-stage risk? In this episode of The Business of Neurotech, Adam Fraser sits down with Matias Serebrinsky, Founding Partner at PsyMed Ventures, a specialist venture capital fund investing in frontier brain and mental health technologies. Matias brings a dual perspective as both a former startup
Richard Mulry Talks Health System Venture Capital and Neurotech Investing
Richard Mulry Talks Health System Venture Capital and Neurotech Investing Jul 27, 2026 2431 How do you turn promising neurotechnology into solutions that can actually work inside healthcare systems? In this episode of The Business of Neurotech Podcast, Adam Fraser is joined by Richard Mulry, President and CEO of Northwell Holdings, the for-profit venture investment arm of Northwell Health, to explore what it takes to identify, invest in, and scale innovation in clinical care. Richard exp
Nicolas Vachicouras Talks BCI Market Dynamics and Start Up Life
Nicolas Vachicouras Talks BCI Market Dynamics and Start Up Life Jul 13, 2026 2231 What does it take to build a BCI company around better hardware, stronger data, and a long-term view of how the brain will be decoded? In this episode of The Business of Neurotech, host Adam Fraser is joined by Nicolas Vachicouras, CEO and co-founder of Neurosoft Bioelectronics, to discuss his path from microelectronics and nanotechnology into the BCI space, and how Neurosoft is developing soft, s
Ryan Field Talks Kernel and Neuroscience as a Service
Ryan Field Talks Kernel and Neuroscience as a Service Jun 29, 2026 2331 What does it take to build a brain measurement company from the ground up and turn neuroscience into a scalable service? In this episode of The Business of Neurotech, host Adam Fraser is joined by Ryan Field, CEO of Kernel, to talk about what it means to build brain technology in an emerging market. Adam and Ryan discuss Ryan’s path from electrical engineering and sensing technology into neurotech
David Eagleman Talks Media, Startups, and Neuroscience
David Eagleman Talks Media, Startups, and Neuroscience Jun 15, 2026 2482 How do you turn neuroscience ideas into real businesses without losing sight of the science? In this episode of The Business of Neurotech, host Adam Fraser sits down with neuroscientist, author, podcaster, entrepreneur, and Stanford educator David Eagleman to explore his journey across academia and neurotech startups. David discusses how he shifted from running a traditional neuroscience lab to bu
Naveen Rao Talks Neurotech Market Dynamics
Naveen Rao Talks Neurotech Market Dynamics Jun 1, 2026 2523 Where is neurotech money really flowing, and what do the numbers say about where the industry is heading next? In this episode of The Business of Neurotech, host Adam Fraser sits down with Naveen Rao, founder of Patchwise Labs, curator of Neurotech Futures, and Forbes contributor covering neurotechnology’s impact on business and society. In their conversation, Naveen shares how a career spanning p
Mariam Khayretdinova talks EEG, AI and Psychiatry
Mariam Khayretdinova talks EEG, AI and Psychiatry May 18, 2026 2399 What if the future of psychiatry depended less on subjective questionnaires and more on biological data, scalable brain models, and artificial intelligence? In this episode of The Business of Neurotech, host Adam Fraser sits down with Mariam Khayretdinova, Founder and CEO of Brainify.AI, a company building electroencephalography (EEG) foundation models for precision neuroscience. Mariam brings a m
Amy Kruse Talks Venture Investing in Neurotech
Amy Kruse Talks Venture Investing in Neurotech May 4, 2026 2514 What does it take to turn cutting-edge brain science into real-world impact? In this episode of The Business of Neurotech Podcast, host Adam Fraser is joined by Dr Amy Kruse, General Partner and CIO (Chief Investment Officer) at Satori Neuro, whose career spans neuroscience research, DARPA (Defense Advanced Research Projects Agency) program leadership, and venture investing. Dr Kruse shares how he
Keith Murphy Talks Focused Ultrasound and Start-Up Life
Keith Murphy Talks Focused Ultrasound and Start-Up Life Apr 27, 2026 2168 Can focused ultrasound finally make deep brain stimulation scalable, non-invasive, and practical for everyday patients? In this episode of The Business of Neurotech, host Adam Fraser sits down with Keith Murphy, co-founder and CTO of Attune Neurosciences, to explore how his path from behavioural neuroscience and optogenetics led to a company building wearable focused ultrasound technology for brai
Michael Brotherton Talks Neurotech Market Dynamics and Neurotech Investing
Michael Brotherton Talks Neurotech Market Dynamics and Neurotech Investing Apr 22, 2026 2163 What does it really take to turn neurotechnology into a scalable business? In this episode of The Business of Neurotech, host Adam Fraser sits down with Michael Brotherton, co-founder and managing partner at Dragonfly 44, to explore the capital, strategy, and market forces shaping the sector. Michael talks about his journey from science into investment banking and how this ultimately led him to es

Recommended